P2X7 is one of the best characterized purinergic receptors in the context of cancer (73), including ovarian (74), mesothelioma (75), pancreatic cell (76), osteosarcoma cell (77), endometrial (78) and skin cancer (79, 80). This evidence concerns the gene P2RX7 and skin neoplasm.